CN103110926A - Medicine for treating periodontitis - Google Patents

Medicine for treating periodontitis Download PDF

Info

Publication number
CN103110926A
CN103110926A CN 201310085190 CN201310085190A CN103110926A CN 103110926 A CN103110926 A CN 103110926A CN 201310085190 CN201310085190 CN 201310085190 CN 201310085190 A CN201310085190 A CN 201310085190A CN 103110926 A CN103110926 A CN 103110926A
Authority
CN
China
Prior art keywords
parts
radix
herba
fructus
folium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 201310085190
Other languages
Chinese (zh)
Inventor
朱桂芝
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 201310085190 priority Critical patent/CN103110926A/en
Publication of CN103110926A publication Critical patent/CN103110926A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a medicine for treating periodontitis. The medicine is prepared from the following substances in parts by weight: 5-10 parts of radix scrophularise, 10-20 parts of dried gingers, 20-30 parts of dogwood, 10-20 parts of balloon flowers, 15-25 parts of angelica dahurica, 5-15 parts of inula britannica chinensis, 10-30 parts of seeds of cowherb, 1-15 parts of fibraurea recisa, 10-20 parts of radix sileris, 15-30 parts of herba ephedrae, 20-30 parts of terminaliae billericae, 1-20 parts of morinda officinalis, 1-20 parts of greater celandine, 10-25 parts of rhizoma imperatae, 10-30 parts of fructus xanthil, 1-20 parts of oil oranges, 15-20 parts of murraya jasminorage, 10-20 parts of morning glory seeds, 15-20 parts of Japanese inula herbs, 15-30 parts of antifebrile dichroa, 10-20 parts of clinopodium polycephalum, 10-25 parts of senna leaves, 5-15 parts of aleppo avens, 1-20 parts of uniflower swisscentaury roots, 15-25 parts of dahurian rhododendron leaves, 15-25 parts of discolorous clinquefoil roots, 10-20 parts of sealwort, 15-25 parts of cortex mori radicis, 20-30 parts of lindley eupatorium, 1-20 parts of lotus stamen and 10-25 parts of rhododendron molle. The medicine for treating the periodontitis disclosed by the invention has natural materials, is good in safety, clear in curative effect and suitable for large-scale clinical popularization.

Description

A kind of medicament for the treatment of periodontitis
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of medicament for the treatment of periodontitis.
Background technology
Periodontitis is the periodontal a kind of chronic destructive disease impaired than deep tissues.Dental pain can appear during the periodontitis acute attack, the multiple symptoms such as the tooth swelling around the eyes is swollen, odontoseisis, have a strong impact on patient's masticatory function.Acute inflammation can be controlled and alleviate to the western medicine acute periodontitis quickly, but its untoward reaction is also apparent, as the appearance of the untoward reaction such as anaphylaxis, gastrointestinal irritation, leucocytes reduction.
Summary of the invention
The purpose of this invention is to provide a kind of medicament for the treatment of periodontitis.
in order to realize purpose of the present invention, the invention provides a kind of medicament for the treatment of periodontitis, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Semen Vaccariae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Herba Ephedrae 15-30 part, Fructus Terminaliae Billericae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Herba Inulae 15-20 part, Radix Dichroae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Rhizoma Polygonati 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Stamen Nelumbinis 1-20 part and Flos Rhododendri Mollis 10-25 part.
preferably, the medicament for the treatment of periodontitis of the present invention is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 13 parts of Flos Inulaes, 28 parts of Semen Vaccariae, 11 parts of Herba Aristolochiaes, 17 parts of Radix Saposhnikoviaes, 24 parts, Herba Ephedrae, 27 parts of Fructus Terminaliae Billericaees, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Rhizoma Imperataes, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Semen Pharbitidiss, 19 parts of Herba Inulae, 15 parts of Radix Dichroaes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Rhizoma Polygonatis, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Stamen Nelumbiniss and Flos Rhododendri Mollis.
More preferably, described medicament can be tablet, dispersible tablet, capsule or decoction.
Whole compositions of the medicament for the treatment of periodontitis of the present invention are all natural materials, and safety is better, and curative effect is clear and definite, are suitable for large-scale promotion clinically.
The specific embodiment
Further illustrate the present invention below by embodiment.It should be understood that embodiments of the invention are for explanation the present invention rather than limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Except as otherwise noted, otherwise the percent in the present invention is percetage by weight.
Embodiment decoction of the present invention
take Radix Scrophulariae 7 grams, Rhizoma Zingiberis 13 grams, Fructus Corni 22 grams, Radix Platycodonis 15 grams, the Radix Angelicae Dahuricae 21 grams, Flos Inulae 13 grams, Semen Vaccariae 28 grams, Herba Aristolochiae 11 grams, Radix Saposhnikoviae 17 grams, Herba Ephedrae 24 grams, Fructus Terminaliae Billericae 27 grams, Radix Morindae Officinalis 18 grams, Herba Chelidonii 17 grams, Rhizoma Imperatae 23 grams, Fructus Xanthii 21 grams, Fructus Phyllanthi 16 grams, Folium Et Cacumen Murrayae 16 grams, Semen Pharbitidis 17 grams, Herba Inulae 19 grams, Radix Dichroae 15 grams, Herba Clinopodii 14 grams, Folium Sennae 21 grams, Radix seu Herba Gei aleppici 11 grams, Radix Rhapontici 13 grams, Folium Rhododendri Daurici 23 grams, Herba Potentillae Discoloris 24 grams, Rhizoma Polygonati 14 grams, Cortex Mori 25 grams, Herba Eupatorii Lindleyani 26 grams, Stamen Nelumbinis 16 grams and Flos Rhododendri Mollis 24 grams, add 3150 milliliters of entry, in being housed, heated 6 hours under 90 ℃ by the flask of condensing tube, filter.Filtrate is concentrated into 920 milliliters, namely gets decoction of the present invention.
Experimental example
Diagnostic criteria with reference to Chinese Medical Association formulate " the clinic diagnosis guide. the stomatology fascicle " relevant criterion carry out (Chinese Medical Association. the clinic diagnosis guide. the stomatology fascicle. Beijing: People's Health Publisher, 2004; 25-26.).That is: 1. the degree of depth>3mm is examined in spy, and attachment loss>1mm is arranged.2. the visible redness of periodontal pocket surface gingiva or spy are examined rear as seen hemorrhage.3. X-ray film prompting phatnoma bone height reduces.
Choose the 60 routine patients that meet above-mentioned standard, male 30 examples, female's 30 examples; 17 years old-44 years old age.
Decoction with embodiment 1 preparation is treated, every day 3 times, each oral 100 milliliters.Treated for 1 week continuously.
Criterion of therapeutical effect
Produce effects: the disappearance of swelling and ache of gingival hemorrhage pyorrhea, odontoseisis alleviates, depth of pocket decline 2mm, gingival index drop by half, gingival hemorrhage index are 0; Take a turn for the better: the alleviation of swelling and ache of gingival hemorrhage pyorrhea, odontoseisis alleviates, and depth of pocket decline 1mm, gingival hemorrhage index are 1; Invalid: the gingival hemorrhage pyorrhea symptom that swells and ache has no obvious improvement, and odontoseisis is without alleviating, and depth of pocket is without decline.
Result
Produce effects 56 examples in 60 routine patients, 4 examples take a turn for the better.

Claims (3)

1. medicament for the treatment of periodontitis, it is characterized in that, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Semen Vaccariae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Herba Ephedrae 15-30 part, Fructus Terminaliae Billericae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Herba Inulae 15-20 part, Radix Dichroae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Rhizoma Polygonati 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Stamen Nelumbinis 1-20 part and Flos Rhododendri Mollis 10-25 part.
2. the medicament for the treatment of periodontitis according to claim 1, it is characterized in that, it is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 13 parts of Flos Inulaes, 28 parts of Semen Vaccariae, 11 parts of Herba Aristolochiaes, 17 parts of Radix Saposhnikoviaes, 24 parts, Herba Ephedrae, 27 parts of Fructus Terminaliae Billericaees, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Rhizoma Imperataes, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Semen Pharbitidiss, 19 parts of Herba Inulae, 15 parts of Radix Dichroaes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Rhizoma Polygonatis, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Stamen Nelumbiniss and Flos Rhododendri Mollis.
3. the medicament for the treatment of periodontitis according to claim 1, is characterized in that, described medicament can be tablet, dispersible tablet, capsule or decoction.
CN 201310085190 2013-03-18 2013-03-18 Medicine for treating periodontitis Pending CN103110926A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201310085190 CN103110926A (en) 2013-03-18 2013-03-18 Medicine for treating periodontitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201310085190 CN103110926A (en) 2013-03-18 2013-03-18 Medicine for treating periodontitis

Publications (1)

Publication Number Publication Date
CN103110926A true CN103110926A (en) 2013-05-22

Family

ID=48409336

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201310085190 Pending CN103110926A (en) 2013-03-18 2013-03-18 Medicine for treating periodontitis

Country Status (1)

Country Link
CN (1) CN103110926A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105596784A (en) * 2016-02-17 2016-05-25 孙茂志 Traditional Chinese medicine composition for treating periodontitis

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105596784A (en) * 2016-02-17 2016-05-25 孙茂志 Traditional Chinese medicine composition for treating periodontitis

Similar Documents

Publication Publication Date Title
CN1739611A (en) Stasis relieving oral liquid for treating rhinitis and its prepn
CN101670051B (en) Traditional Chinese medicine for treating toothache
CN103301400A (en) Traditional Chinese medicinal composition for treating chronic atrophic gastritis and preparation method of traditional Chinese medicinal composition
CN102579677B (en) Chinese medicinal composition for treating brain glioma
CN102228638A (en) Chinese medicinal preparation for treating toothache
CN102727803B (en) Medicine for treating periodontitis
CN102309663B (en) Medicament for controlling dental caries
CN103110926A (en) Medicine for treating periodontitis
CN101518607B (en) Traditional Chinese medicine for treating carcinoma of kidney
CN102631448B (en) Medicament for treating periodontitis
CN102580035B (en) Medicament for treating periodontitis
CN102380063A (en) Chinese medicament for treating diabetic foot
CN102293916B (en) Medicine for treating orthodontic gingivitis
CN102526385B (en) Medicament for treating climacteric syndrome
CN101843778B (en) Chinese medicament for treating ichthyosis
CN101502597B (en) Medicament for treating stomachache and preparation method thereof
CN101518611A (en) Traditional Chinese medicine for treating bone tumor
CN103157091A (en) Drug for treating empyrosis
CN102895455B (en) Drug for treating periodontitis
CN103007236B (en) Chinese medicinal composition for treating ankylosing spondylitis
CN103110927A (en) Medicine for treating gingivitis
CN1682877A (en) Medicinal composition for treating cyst
CN103110924A (en) Medicine for treating hemorrhoids
CN103638319A (en) Preparation method of medicine for treating periodontitis
CN101843768B (en) Chinese medicament for treating climacteric syndromes

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20130522